Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease-Reference-Cited by-同舟云学术

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Published:2013-05-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sigterman Kirsten E¹,van Pinxteren Bart²,Bonis Peter A³,Lau Joseph⁴,Numans Mattijs E⁵

Affiliation:

1. Technische Universität München Klinikum rechts der Isar; Institut für Allgemeinmedizin / Institute of General Practice; Orleansstrasse 47 Munich Germany 81667

2. Huisartsen Oog in Al; Handelstraat 55a Utrecht Utrecht Netherlands 3533GH

3. Tufts Medical Centre/Division of Gastroenterology; Tufts Medical Centre; 800 Washington Street Box 63 Boston MA USA 02111

4. Brown University Public Health Program; Center for Evidence-based Medicine; 121 S. Main Street Providence RI USA 02912

5. VU University Medical Center; Department of General Practice and Elderly Care Medicine, EMGO Institute for Health and Care Research, and Alzheimer Center; Van der Boechorststraat 7 12 Amsterdam Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002095.pub5/fullpdf

Reference110 articles.

1. A randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease;Armstrong;American Journal of Gastroenterology,2001

2. Pantoprazole rapidly improves health-related quality of life in patients with heartburn;Paré;Journal of Clinical Gastroenterology,2003

3. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and H2-RA-start' management strategies in primary care - the CADET-HR Study;Armstrong;Alimentary Pharmacology and Therapeutics,2005

4. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine;Bardhan;BMJ,1999

5. Symptomatic gastroesophageal reflux disease (GERD): intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management;Bardhan;Gastroenterology,1997

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal trends in use of antisecretory agents among patients administered clopidogrel‐based dual antiplatelet therapy after percutaneous coronary intervention;Pharmacoepidemiology and Drug Safety;2024-05-21

2. Efficacy and Safety of Omeprazole for the Treatment of Acid Peptic Disorders: A Systematic Review and Meta-Analysis;International Journal of Clinical Practice;2024-03-28

3. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach;Expert Review of Clinical Immunology;2024-02-26

4. Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología;Revista de Gastroenterología de México;2024-01

5. Infant gastroesophageal reflux disease management consensus;Acta Paediatrica;2023-12-20